E-cadherin and Breast Cancer
Author Information
Author(s): JL Jones, JE Royall, RA Walker
Primary Institution: University of Leicester
Hypothesis
The study aims to examine the expression of E-cadherin in primary breast carcinomas and its relationship with clinicopathological parameters.
Conclusion
The study found a significant association between reduced E-cadherin expression and the presence of lymph node metastasis in breast cancer.
Supporting Evidence
- 93% of infiltrating ductal carcinomas showed some evidence of E-cadherin staining.
- Reduced membrane reactivity of E-cadherin was significantly associated with lymph node metastasis.
- A highly significant correlation was found between cytoplasmic E-cadherin reactivity and lymph node metastasis.
Takeaway
E-cadherin is a protein that helps cells stick together, and in breast cancer, lower levels of it can mean the cancer has spread to lymph nodes.
Methodology
The study used immunohistochemical techniques to examine E-cadherin expression in breast cancer tissue samples and correlated findings with clinicopathological data.
Limitations
The study's findings may not apply to all breast cancer types due to the small sample sizes of certain carcinoma types.
Participant Demographics
The study included 187 patients with various types of breast carcinoma, including infiltrating ductal and lobular carcinomas.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website